Deciphera(DCPH) - 2023 Q1 - Earnings Call Transcript
Tucker Kelly Matt? Matt Sherman - Chief Medical Officer Thank you, operator. Welcome, and thank you for joining us today to discuss Deciphera's first quarter 2023 financial results. I'm Jen Larson, Senior Vice President of Finance and Investor Relations. Together, QINLOCK and vimseltinib have the potential to benefit thousands of patients around the world, with a peak worldwide sales potential of over $1 billion. We look forward to reporting the MOTION study results and initiating the INSIGHT study later th ...